Meridiem Capital Partners’s DexCom DXCM Stock Holding History

Meridiem Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-118,345	Closed	-$7.43M	–	98
2026 Q1	$7.43M	Buy	+118,345	New	+$8.24M	0.48%	56
2025 Q4	–	Sell	-269,926	Closed	-$18.2M	–	81
2025 Q3	$18.2M	Buy	269,926 +74,577	+38%	+$5.9M	1.16%	34
2025 Q2	$17.1M	Buy	+195,349	New	+$15.3M	1.2%	36
2025 Q1	–	Sell	-413,498	Closed	-$32.2M	–	71
2024 Q4	$32.2M	Buy	+413,498	New	+$30.6M	2.83%	8

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Meridiem Capital Partners's DXCM Position: Q2 2026 in Review

Meridiem Capital Partners sold out of DexCom (DXCM) in Q2 2026, closing a stake of 118,345 shares — an estimated $7.43M sold.

Meridiem Capital Partners first reported a position in DXCM in Q4 2024 and held it in 4 quarters. The position peaked at $32.2M in Q4 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Meridiem Capital Partners reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Meridiem Capital Partners sold 118,345 DexCom shares in Q2 2026, an estimated $7.43M.
Meridiem Capital Partners first reported a position in DexCom in Q4 2024 and held it in 4 quarters.
Meridiem Capital Partners's DexCom position peaked at $32.2M in Q4 2024.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.